Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection (Q37058032)

18 August 2017

1 reference

title

Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection (English)

1 reference

methicillin-resistant Staphylococcus aureus

18 August 2017

0 references

Staphylococcus aureus

1 reference

1 reference

Richard A Proctor

1

1 reference

PubMed ID

18197761

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

Clinical Infectious Diseases

18 August 2017

1 reference

18 August 2017

46

1 reference

18 August 2017

4

1 reference

18 August 2017

584-593

1 reference

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study

18 August 2017

1 reference

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus

21 January 2018

1 reference

Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse

21 January 2018

1 reference

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

21 January 2018

1 reference

The economic impact of Staphylococcus aureus infection in New York City hospitals

21 January 2018

1 reference

The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database

21 January 2018

1 reference

Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.

21 January 2018

1 reference

Community-associated MRSA--resistance and virulence converge

21 January 2018

1 reference

Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?

21 January 2018

1 reference

Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak

21 January 2018

1 reference

Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation

21 January 2018

1 reference

A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection

21 January 2018

1 reference

Impact of community-associated, methicillin-resistant Staphylococcus aureus on management of the skin and soft tissue infections in children

21 January 2018

1 reference

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

21 January 2018

1 reference

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.

21 January 2018

1 reference

Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic

21 January 2018

1 reference

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

21 January 2018

1 reference

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

21 January 2018

1 reference

Methicillin-resistant staphylococci and their treatment in the intensive care unit

21 January 2018

1 reference

Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Role of linezolid in the treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections

21 January 2018

1 reference

Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia

21 January 2018

1 reference

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus

21 January 2018

1 reference

Thymidyl biosynthesis enzymes as antibiotic targets

21 January 2018

1 reference

THE INHIBITION OF THE BACTERIOSTATIC ACTION OF SULFONAMIDE DRUGS BY SUBSTANCES OF ANIMAL AND BACTERIAL ORIGIN.

21 January 2018

1 reference

SULFONAMIDE-RESISTANT STAPHYLOCOCCI: CORRELATION OF IN VITRO SULFONAMIDE-RESISTANCE WITH SULFONAMIDE THERAPY

21 January 2018

1 reference

Structure and function of the dihydropteroate synthase from Staphylococcus aureus

21 January 2018

1 reference

Resistance to trimethoprim-sulfamethoxazole

21 January 2018

1 reference

Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004.

21 January 2018

1 reference

In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar

21 January 2018

1 reference

Co-trimoxazole–Sensitive, Methicillin-ResistantStaphylococcus aureus, Israel, 1988–1997

21 January 2018

1 reference

Evolving epidemiology of pediatric Staphylococcus aureus cutaneous infections in a Baltimore hospital

21 January 2018

1 reference

Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999.

21 January 2018

1 reference

Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

21 January 2018

1 reference

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

21 January 2018

1 reference

Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland

21 January 2018

1 reference

SULFONAMIDE-FAST PNEUMOCOCCI. A CLINICAL REPORT OF TWO CASES OF PNEUMONIA TOGETHER WITH EXPERIMENTAL STUDIES ON THE EFFECTIVENESS OF PENICILLIN AND TYROTHRICIN AGAINST SULFONAMIDE-RESISTANT STRAINS.

21 January 2018

1 reference

Mucolytics in cystic fibrosis.

21 January 2018

1 reference

Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and 'folates'.

21 January 2018

1 reference

Effect of thymidine on activity of trimethoprim and sulphamethoxazole

21 January 2018

1 reference

Cluster of clinical isolates of epidemic methicillin-resistant Staphylococcus aureus (EMRSA) with a negative deoxyribonuclease (DNase) test-implications for laboratory diagnosis and infection control

21 January 2018

1 reference

Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis

21 January 2018

1 reference

Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination

21 January 2018

1 reference

In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.

21 January 2018

1 reference

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

21 January 2018

1 reference

Pneumatoceles in postpneumonic empyema: an algorithmic approach.

21 January 2018

1 reference

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

21 January 2018

1 reference

Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis

21 January 2018

1 reference

Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.

21 January 2018

1 reference

Trimethoprim-sulphamethoxazole treatment in staphylococcal endocarditis and gram-negative septicemia.

21 January 2018

1 reference

Bacterial endocarditis over prosthetic valves treated with trimethoprim-sulphamethoxazole combination

21 January 2018

1 reference

Trimethoprim-sulfamethoxazole treatment of multiantibiotic-resistant staphylococcal endocarditis and meningitis.

21 January 2018

1 reference

Efficacy of trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus: a report from Tunisia

21 January 2018

1 reference

Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study

21 January 2018

1 reference

Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections

21 January 2018

1 reference

Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B.

21 January 2018

1 reference

Enhanced post-stationary-phase survival of a clinical thymidine-dependent small-colony variant of Staphylococcus aureus results from lack of a functional tricarboxylic acid cycle

21 January 2018

1 reference

Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease

21 January 2018

1 reference

Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis.

21 January 2018

1 reference

Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease.

21 January 2018

1 reference

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/525536

1 reference

18 August 2017

1 reference

PubMed ID

18197761